Adamas Pharma (ADMS) – Trading Halts
-
Adamas Pharma (ADMS) to Resume Trading at 2:35 p.m.
-
Adamas Pharma (ADMS) Announces FDA Approval for Second Indication for GOCOVRI as Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes
-
-
-
-
-
-
-
-
-
-
Back to ADMS Stock Lookup